What is Polaryx Therapeutics, Inc. 's retained earnings?

Polaryx Therapeutics, Inc. (PLYX) reported retained earnings of -$102.18M in Q1 2026.

What does retained earnings mean?

Cumulative net income earned since inception minus all dividends paid — the total profits reinvested in the business over its lifetime.

Polaryx Therapeutics, Inc. PLYX Retained Earnings

Retained Earnings at other companies

BioMarin PharmaceuticalsBMRN

$259.73M+2,983%

Zevra Therapeutics, Inc.ZVRA

-$384.17M+24.4%

Eton Pharmaceuticals, Inc.ETON

-$110.94M-1.3%

XER

Xeris Biopharma Holdings, Inc.XERS

-$669.07M+1.8%

Relay Therapeutics, Inc.RLAY

-$2.09B-15.0%

PVL

Palvella TherapeuticsPVLA

-$151.22M-48.4%

Other financials

Income statement

See full

Operating income-$2.0M+61.2%

Net income-$2.5M+49.6%

EPS (diluted)-$0.05+54.5%

Balance sheet

See full

Cash & equivalents$3.1M+1,132%

Total equity$2.5M-41.5%

Total assets$3.5M—

Cash flow

See full

Operating cash flow-$2.1M-191%

Valuation

See full

Market cap$132.59M-87.6%

Returns & leverage

See full

Return on equity-1,209.8%—

Current ratio3.5×—

Where this comes from

Reported directly by Polaryx Therapeutics, Inc. in its filing.

Tagged under the XBRL concept us-gaap:RetainedEarningsAccumulatedDeficit.

The official record: Polaryx Therapeutics, Inc. ’s 10-Q, filed May 15, 2026, on SEC EDGAR. View the filing →

Ask your AI about Polaryx Therapeutics, Inc. 's retained earnings.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Polaryx Therapeutics, Inc. 's retained earnings?: Polaryx Therapeutics, Inc. (PLYX) reported retained earnings of -$102.18M in Q1 2026.
What does retained earnings mean?: Cumulative net income earned since inception minus all dividends paid — the total profits reinvested in the business over its lifetime.